12:00 AM
Jan 17, 2011
 |  BC Week In Review  |  Company News  |  Deals

Aerogen, Dance Pharma Inc deal

Aerogen and Dance partnered to develop Dance's inhaled insulin using Aerogen's OnQ aerosol technology. Under the deal, Dance received exclusive, worldwide rights...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >